Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | PLA2G2C | Q5R387 | 2/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4815158 | 0.95 | TDP1 (0.54) | TDP1TSHRHSD17B10THRBALDH1A1 | |
| SCHEMBL11240653 | 0.95 | TDP1 (0.54) | TDP1TSHRHSD17B10THRBALDH1A1 | |
| SCHEMBL11252889 | 0.95 | TDP1 (0.54) | TDP1TSHRHSD17B10THRBALDH1A1 | |
| SCHEMBL1029759 | 0.91 | TSHR (0.48) | TDP1TSHRHSD17B10THRBALDH1A1 | |
| SCHEMBL7191777 | 0.90 | TSHR (0.46) | TDP1TSHRTHRBALDH1A1PLA2G2C | |
| SCHEMBL27660620 | 0.87 | TSHR (0.56) | TSHRPLA2G2CUSP2 | |
| SCHEMBL15302991 | 0.87 | TSHR (0.56) | TSHRPLA2G2CUSP2 | |
| SCHEMBL2219398 | 0.87 | TSHR (0.52) | TDP1TSHRTHRBALDH1A1 | |
| SCHEMBL5984326 | 0.86 | TSHR (0.44) | TDP1TSHRTHRBALDH1A1 | |
| SCHEMBL27707717 | 0.86 | TSHR (0.44) | TDP1TSHRTHRBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11859055-B2 | Polysiloxane monomer and method for producing same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-01-02 | — | — | US | disclosed |
| US-20210238363-A1 | POLYSILOXANE MONOMER AND METHOD FOR PRODUCING SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-08-05 | — | — | US | disclosed |
| EP-3805276-A1 | POLYSILOXANE MONOMER AND METHOD FOR PRODUCING SAME | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-04-14 | — | — | EP | disclosed |
| US-9780374-B2 | Binder for electrodes of lithium secondary batteries, and lithium secondary battery which uses electrode produced using binder for electrodes of lithium secondary batteries | DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) | 2017-10-03 | — | — | US | disclosed |
| US-20160362375-A1 | Iodine(III)-Mediated Radiofluorination | THE GENERAL HOSPITAL CORPORATION | 2016-12-15 | — | — | US | disclosed |
| WO-2009158302-A2 | VISCOUS ALPHA-CYANOACRYLATE COMPOSITIONS | CLOSURE MEDICAL CORPORATION (US) | 2009-12-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160362375-A1 | Iodine(III)-Mediated Radiofluorination | TPO, FLI1, SSTR3 | TDP1 1940/4885TSHR 24/4885HSD17B10 2634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.